The Animal Antibacterial and Antibiotics Market is being driven by several key factors. Rising livestock production and ...

It’s important to maintain a temperature of 77 degrees or cooler, and above freezing, so efficacy is highest when the product ...

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry ... relating to the approval status and labels of approved products may vary from ...

The U.S. FDA Breakthrough Therapy designation is for the treatment of adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and moderate or advanced fibrosis, based on surv ...

While you may think of healthcare as only covering human health, animal and pet health is also a growing sector. Click to ...

Sanofi's wide lineup of branded drugs and vaccines and robust pipeline create strong cash flows and a wide economic moat. Growth of existing products and new product launches should help offset ...

Zoetis excels in innovation, creating new categories and consistently raising the standard of care, outperforming competitors ...

MASH severity is assessed using a scale that ranges from F0 to F4, which measures the level of fibrosis (scarring): 18 Boehringer Ingelheim is a biopharmaceutical company active in both human and ...

In the future, around one third of the new products at Boehringer ... delivered daily at 7 AM Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health.

The board of trustees (the "Board") of NXG Cushing® Midstream Energy Fund (the "Fund") has approved the terms of the issuance of transferable rights ("Rights") to the holders of the Fund's common ...